You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Design, Conduct, and Use of Patient Preference Studies in the Medical Product Life Cycle: A Multi-Method Study
|
|---|---|
| Published in |
Frontiers in Pharmacology, December 2019
|
| DOI | 10.3389/fphar.2019.01395 |
| Pubmed ID | |
| Authors |
Eline van Overbeeke, Rosanne Janssens, Chiara Whichello, Karin Schölin Bywall, Jenny Sharpe, Nikoletta Nikolenko, Berkeley S. Phillips, Paolo Guiddi, Gabriella Pravettoni, Laura Vergani, Giulia Marton, Irina Cleemput, Steven Simoens, Jürgen Kübler, Juhaeri Juhaeri, Bennett Levitan, Esther W. de Bekker-Grob, Jorien Veldwijk, Isabelle Huys |
X Demographics
The data shown below were collected from the profiles of 32 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Sweden | 3 | 9% |
| Belgium | 3 | 9% |
| United Kingdom | 3 | 9% |
| United States | 2 | 6% |
| France | 2 | 6% |
| Switzerland | 2 | 6% |
| Italy | 1 | 3% |
| Austria | 1 | 3% |
| Spain | 1 | 3% |
| Other | 3 | 9% |
| Unknown | 11 | 34% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 26 | 81% |
| Scientists | 4 | 13% |
| Science communicators (journalists, bloggers, editors) | 1 | 3% |
| Practitioners (doctors, other healthcare professionals) | 1 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 103 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 103 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 11 | 11% |
| Researcher | 10 | 10% |
| Student > Bachelor | 9 | 9% |
| Student > Ph. D. Student | 9 | 9% |
| Other | 8 | 8% |
| Other | 10 | 10% |
| Unknown | 46 | 45% |
| Readers by discipline | Count | As % |
|---|---|---|
| Pharmacology, Toxicology and Pharmaceutical Science | 11 | 11% |
| Medicine and Dentistry | 10 | 10% |
| Business, Management and Accounting | 6 | 6% |
| Nursing and Health Professions | 3 | 3% |
| Economics, Econometrics and Finance | 3 | 3% |
| Other | 20 | 19% |
| Unknown | 50 | 49% |
Attention Score in Context
This research output has an Altmetric Attention Score of 25. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 July 2022.
All research outputs
#1,573,597
of 26,017,215 outputs
Outputs from Frontiers in Pharmacology
#621
of 20,002 outputs
Outputs of similar age
#37,442
of 481,837 outputs
Outputs of similar age from Frontiers in Pharmacology
#14
of 332 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 20,002 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 481,837 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 332 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.